Foster City, CA, United States of America

Gerald J Wallweber

This inventor holds 10 USPTO granted patents and 7 published patent applications, plus 4 CIPO patents and 3 EPO patents. Top assignees: Laboratory Corporation of America Holdings, Monogram Biosciences, Inc., Other. Active years: 2007-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gerald J Wallweber. Retrieved from https://idiyas.com/inventor/gerald-j-wallweber

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10 (Patent Applications = 7)

% Patents Active = 90.0

CIPO Patents = 4 (Patent Applications = 3)

EPO Patents = 3 (Patent Applications = 5)

Average Co-Inventor Count = 3.1

ph-index = 3

Forward Citations = 73(Granted Patents)

Location History:

Woodside, CA (US) (2007)
La Honda, CA (US) (2008)
Foster City, CA (US) (2015 - 2024)

Company Filing History:

5 out of 127

Laboratory Corporation of America Holdings

patents

4 out of 52

Monogram Biosciences, Inc.

patents

1 out of 834,513

Other

patents

Years Active: 2007-2025

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12411130 - Methods of assessing protein interactions between cells (2025-09-09),

2. 11579148 - Methods for determining the likelihood of survival and for predicting likelihood of metastasis in cancer patients (2023-02-14),

3. 11401344 - Methods for determining the likelihood of survival and for predicting likelihood of metastasis in cancer patients (2022-08-02),

4. 10451614 - Methods of assessing protein interactions between cells (2019-10-22),

5. 10273308 - Methods of producing antibodies specific for p95 (2019-04-30),

6. 9939447 - Methods and compositions for analyzing proteins (2018-04-10),

7. 9110075 - Compositions for analyzing proteins (2015-08-18),

8. 9081019 - Methods and assays for measuring p95 and/or p95 complexes in a sample and antibodies specific for p95 (2015-07-14),

9. 7402397 - Detecting and profiling molecular complexes (2008-07-22),

10. 7255999 - Methods and compositions for analyzing proteins (2007-08-14),

Gerald J Wallweber: Innovator in Cancer Prognostics

Introduction

Gerald J Wallweber, based in Foster City, CA, has made significant contributions to the field of medical innovation, particularly in cancer research. With a remarkable portfolio of 9 patents, Wallweber is recognized for his groundbreaking work in predicting the survival likelihood and metastasis in cancer patients.

Latest Patents

Among his latest patents, Wallweber developed methods for determining the likelihood of survival and predicting the likelihood of metastasis in cancer patients. This invention focuses on accurately quantifying HER2 and/or p95 expression in subjects with HER2 positive cancer, shedding light on the risk of brain relapse for these patients. His innovative approaches are aimed at improving diagnostic accuracy and patient outcomes in oncology.

Career Highlights

Throughout his career, Gerald has collaborated with prominent organizations such as Monogram Biosciences, Inc. and Laboratory Corporation of America Holdings. His work in these institutions has cemented his role as a key player in advancing cancer diagnostics and therapeutics.

Collaborations

Working alongside talented professionals like Sharat Singh and Hossein Salimi-Moosavi, Wallweber has contributed to a wealth of knowledge and innovation in the medical field. These collaborations have paved the way for new techniques and methodologies that enhance understanding of cancer biology.

Conclusion

Gerald J Wallweber’s dedication to cancer research and his innovative inventions have positioned him as a notable inventor in the medical industry. His methods for assessing cancer prognostics showcase the vital link between innovation and improved healthcare solutions.

Profile summary based on public USPTO records.